491 related articles for article (PubMed ID: 11158002)
1. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
[TBL] [Abstract][Full Text] [Related]
2. Sleep apnea is a manifestation of the metabolic syndrome.
Vgontzas AN; Bixler EO; Chrousos GP
Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
[TBL] [Abstract][Full Text] [Related]
3. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
[TBL] [Abstract][Full Text] [Related]
4. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.
Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T
Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833
[TBL] [Abstract][Full Text] [Related]
5. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance.
Vgontzas AN; Bixler EO; Chrousos GP
J Intern Med; 2003 Jul; 254(1):32-44. PubMed ID: 12823641
[TBL] [Abstract][Full Text] [Related]
6. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.
Tasali E; Van Cauter E; Ehrmann DA
J Clin Endocrinol Metab; 2006 Jan; 91(1):36-42. PubMed ID: 16219719
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.
Fogel RB; Malhotra A; Pillar G; Pittman SD; Dunaif A; White DP
J Clin Endocrinol Metab; 2001 Mar; 86(3):1175-80. PubMed ID: 11238505
[TBL] [Abstract][Full Text] [Related]
8. Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome.
Suri J; Suri JC; Chatterjee B; Mittal P; Adhikari T
Sleep Med; 2016 Aug; 24():32-39. PubMed ID: 27810183
[TBL] [Abstract][Full Text] [Related]
9. [Polycystic ovarian syndrome and obstructive sleep apnea].
Gateva A; Kamenov Z; Mondeshki Ts; Bilyukov R; Georgiev O
Akush Ginekol (Sofiia); 2013; 52(3):63-8. PubMed ID: 24283067
[TBL] [Abstract][Full Text] [Related]
10. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndrome.
Christ JP; Shinkai K; Corley J; Pasch L; Cedars MI; Huddleston HG
J Clin Sleep Med; 2024 Jun; 20(6):871-877. PubMed ID: 38217476
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
15. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
[TBL] [Abstract][Full Text] [Related]
16. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
Vgontzas AN
Arch Physiol Biochem; 2008 Oct; 114(4):211-23. PubMed ID: 18946782
[TBL] [Abstract][Full Text] [Related]
17. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.
Mokhlesi B; Scoccia B; Mazzone T; Sam S
Fertil Steril; 2012 Mar; 97(3):786-91. PubMed ID: 22264851
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
20. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
